- Previous Close
0.0000 - Open
0.0011 - Bid 0.0015 x --
- Ask 0.0021 x --
- Day's Range
0.0010 - 0.0021 - 52 Week Range
0.0001 - 0.0095 - Volume
64,700 - Avg. Volume
325,218 - Market Cap (intraday)
719,142 - Beta (5Y Monthly) 496.59
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
EHAVE, Inc., a healthcare company, develops medical psychedelics and mental health data platform that integrates with its proprietary and third-party assessment and therapeutic digital applications in Canada. The company offers MegaTeam and Ninja Reflex, a clinically validated digital assessment and rehabilitation software for the patient; and adapts custom and third-party clinically validated digital assessment and rehabilitation software for patient engagement and data modeling. It also offers Ehave Dashboard, a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using blockchain technology. In addition, the company provides a platform for medical practitioners to administer healthcare services to patients at home. EHAVE, Inc. serves clinicians, patients, researchers, pharmaceutical companies, and payors. The company was incorporated in 2011 and is based in Miami, Florida.
www.ehave.com1
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EHVVF
View MorePerformance Overview: EHVVF
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EHVVF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EHVVF
View MoreValuation Measures
Market Cap
719.14k
Enterprise Value
1.69M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-46.01%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.01M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.38M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
2.43M